NCT05109208NARecruiting
The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction
Mayo Clinic
Start Date
10/2/2023
Completion Date
10/31/2028
Summary
Researchers are trying to determine whether there is additional utility to using vibroelastography, a noninvasive ultrasound technique to evaluate for the presence of tissue fibrosis, in conjunction with standard penile duplex Doppler ultrasound to assess erectile function (recovery) after prostate cancer surgery.
Eligibility Criteria
Age Range: 40 years to No maximum
Inclusion criteria include:
* Age \> 40 years
* Clinically localized prostate cancer (American Urological Association Grade Groups 1-2; cT1c or cT2a-b; PSA \< 10) without clinic or imaging evidence of localized extra-prostatic or metastatic disease (i.e. AUA low and favorable intermediate risk prostate cancer)
* International Index of Erectile Function (IIEF) of ≥ 21 points at baseline (no or mild erectile dysfunction)
* Patient-expressed interest in consultation for sexual function (erectile function) preservation/ optimization
* Planned bilateral nerves-paring prostatectomy
Exclusion criteria include:
* Moderate or severe ED based in IIEF criteria (score \< 21)
* History of prior pelvic or penile surgery
* Current or prior androgen deprivation therapy
* Planned non-nerve sparing prostatectomy
Interventions
DIAGNOSTIC_TEST
Ulrasound Vibroelastography (UVE)
Conditions
Prostate Adenocarcinoma
Locations
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States